Sorrento Therapeutics Inc. Daily Stock Analysis

Daily Stock Analysis, SRNE, Sorrento Therapeutics Inc, priceseries

Sorrento Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
2.16
Close
2.12
High
2.23
Low
2.10
Previous Close
2.20
Daily Price Gain
-0.08
YTD High
4.99
YTD High Date
Jan 4, 2022
YTD Low
2.10
YTD Low Date
Mar 7, 2022
YTD Price Change
-2.78
YTD Gain
-56.73%
52 Week High
11.07
52 Week High Date
Jul 1, 2021
52 Week Low
2.10
52 Week Low Date
Mar 7, 2022
52 Week Price Change
-6.67
52 Week Gain
-75.88%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jun 13. 2017
1.60
Jun 20. 2017
1.78
5 Trading Days
11.16%
Link
LONG
Oct 4. 2017
1.77
Oct 18. 2017
2.58
10 Trading Days
45.36%
Link
LONG
Dec 15. 2017
2.95
Dec 21. 2017
3.14
4 Trading Days
6.36%
Link
LONG
Dec 28. 2017
3.65
Feb 1. 2018
6.94
23 Trading Days
90.03%
Link
LONG
Feb 13. 2018
7.25
Feb 27. 2018
8.19
9 Trading Days
12.94%
Link
LONG
Mar 12. 2019
2.18
Mar 27. 2019
4.06
11 Trading Days
86.23%
Link
LONG
Jun 13. 2019
3.15
Jun 25. 2019
3.43
8 Trading Days
8.95%
Link
LONG
Oct 3. 2019
2.32
Oct 7. 2019
2.62
2 Trading Days
12.72%
Link
LONG
Nov 21. 2019
1.60
Dec 19. 2019
3.68
19 Trading Days
130.01%
Link
LONG
Apr 2. 2020
2.02
Apr 17. 2020
2.53
10 Trading Days
25.29%
Link
LONG
May 15. 2020
6.76
May 18. 2020
8.38
1 Trading Days
23.96%
Link
LONG
Jun 18. 2020
4.80
Jul 15. 2020
6.94
18 Trading Days
44.60%
Link
LONG
Jul 30. 2020
8.55
Aug 12. 2020
12.35
9 Trading Days
44.40%
Link
LONG
Sep 16. 2020
8.36
Sep 24. 2020
8.96
6 Trading Days
7.24%
Link
LONG
Sep 25. 2020
9.63
Oct 2. 2020
10.13
5 Trading Days
5.10%
Link
LONG
Jan 14. 2021
7.99
Feb 12. 2021
14.53
20 Trading Days
81.79%
Link
LONG
Jun 1. 2021
7.64
Jun 16. 2021
8.71
11 Trading Days
14.03%
Link
LONG
Jun 22. 2021
8.93
Jul 2. 2021
9.77
8 Trading Days
9.39%
Link
Company Information
Stock Symbol
SRNE
Exchange
NasdaqCM
Company URL
http://www.sorrentotherapeutics.com
Company Phone
858-203-4100
CEO
Henry H. Ji
Headquarters
California
Business Address
4955 DIRECTORS PLACE, SAN DIEGO, CA 92121
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0000850261
About

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.

Description

Sorrento Therapeutics, Inc., a clinical stage biotechnology company, primarily engages in the discovery and development of therapies focused on oncology and the treatment of chronic cancer pain worldwide. It develops therapeutic products for the treatment of auto-immune, inflammatory, neurodegenerative, and infectious diseases. The company offers resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for the treatment of intractable pain at end-stage disease. Its preclinical human therapeutic antibodies include antibody drug conjugates, bispecific approaches, and T-Cell Receptor, as well as Chimeric Antigen Receptor-T Cell (CAR-T) for adoptive cellular immunotherapy for the treatment of solid and liquid tumors. It is also involved in the development of T-007, an anti-CD38 CAR-T cellular therapy for the treatment of multiple myeloma, as well as for additional potential indications, such as amyloidosis and graft-versus-host disease; and T-009, an anti-CD123 CAR-T cellular therapy for the treatment of acute myelogenous leukemia. The company has license and collaboration agreement with Les Laboratoires Servier for the development, manufacture, and commercialization of products using its human immuno-oncology anti-PD-1 mAb STI-A1110. Sorrento Therapeutics, Inc. was founded in 2006 and is based in San Diego, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading